December 2017 Archive
Amarillo researchers identify promising compounds to treat neurodegenerative diseases
New compounds designed and synthesized in the lab of Paul Trippier, Ph.D., show the effects of protecting human neurons from a form of cell death common in neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Tags
- #Abilene
- #Administration
- #Alumni
- #Amarillo
- #Breast Center of Excellence
- #Campus Life
- #COVID-19
- #Dallas
- #Development
- #Diversity
- #Education
- #Emergency
- #Events
- #F. Marie Hall Institute for Rural and Community Health
- #F. Marie Hall SimLife Center
- #Faculty
- #Feature Stories
- #Garrison Institute on Aging
- #General
- #Graduate School of Biomedical Sciences
- #Health
- #Hispanic-Serving Institution
- #Laura W. Bush Institute for Women's Health
- #Lubbock
- #Managed Care
- #Mental Health Initiative
- #Mental Health Resource Hub
- #Military
- #Miscellaneous
- #News Releases
- #Paul L. Foster School of Medicine
- #Permian Basin
- #President
- #Public Art
- #Research
- #School of Health Professions
- #School of Medicine
- #School of Nursing
- #School of Pharmacy
- #School of Population and Public Health
- #Staff
- #Statline
- #Stories
- #Students
- #Team Member Spotlight
- #Texas Tech Physicians
- #The Free Clinic
- #TTUHSC in the News
- #Values
- #Videos
- #Vision
- #Well Beyond
- #Women's Health